Literature DB >> 14280273

INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.

L J POIRIER, T L SOURKES.   

Abstract

Entities:  

Keywords:  BRAIN CHEMISTRY; BRAIN DISEASES; DOPAMINE; EXPERIMENTAL LAB STUDY; GANGLIA, BASAL; MESENCEPHALON; MONKEYS; NOREPINEPHRINE; PATHOLOGY; SUBSTANTIA NIGRA

Mesh：

Substances：

Year:  1965        PMID： 14280273     DOI： 10.1093/brain/88.1.181

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  53 in total

1.  Ventral midbrain stimulation, blood pressure responses and their relation to the dopaminergic nigro-striatal pathways.

Authors:  A Spring; W Winkelmüller
Journal:  Pflugers Arch       Date:  1975-08-12       Impact factor: 3.657

2.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

Review 3.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

4.  Early and selective increase in brain dopamine levels after axotomy.

Authors:  N E Andén; P Bédard; K Fuxe; U Ungerstedt
Journal:  Experientia       Date:  1972-03-15

Review 5.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Alteration of basal ganglia evoked responses by reserpine and L-dopa.

Authors:  W C Koller; C A Berry
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

7.  Extrapyramidal dysfunction with cerebral arteriovenous malformations.

Authors:  J Lobo-Antunes; M D Yahr; S K Hilal
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

8.  Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

Authors:  M J Aminoff; C S Wilcox; M M Woakes; M Kremer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

9.  Huntington's chorea and tryptophan.

Authors:  W R McLeod; D J Horne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

10.  Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease.

Authors:  Steven R Danielson; Jason M Held; Birgit Schilling; May Oo; Bradford W Gibson; Julie K Andersen
Journal:  Anal Chem       Date:  2009-09-15       Impact factor: 6.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.